Rozalina Mccoy is an Endocrinologist in Baltimore, Maryland. Dr. Mccoy has been practicing medicine for over 17 years and is rated as an Elite provider by MediFind in the treatment of Type 2 Diabetes (T2D). Her top areas of expertise are Low Blood Sugar, Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, and Diabetic Hyperglycemic Hyperosmolar Syndrome.

Meegan Chestnut is a primary care provider, practicing in Internal Medicine in Glen Burnie, Maryland. Dr. Chestnut is rated as an Advanced provider by MediFind in the treatment of Type 2 Diabetes (T2D). Her top areas of expertise are Obesity, High Cholesterol, Glucocorticoid-Remediable Aldosteronism, and Familial Hypertension.

Dr. Mathioudakis, an endocrinologist and researcher, has a strong focus on diabetes management and patient care, recognized through awards like the Baltimore Top Doc. He has contributed significantly to diabetes research, authoring over 150 publications and participating in the development of consensus guidelines in the field. His studies have offered valuable insights into using health informatics for diabetes prevention and management. After graduating from the Johns Hopkins University School of Medicine and completing his training in Internal Medicine and a fellowship in Endocrinology, Diabetes, & Metabolism, Dr. Mathioudakis joined the faculty in the Division of Endocrinology, Diabetes & Metabolism in 2012. He earned a Master of Health Science in clinical investigation in 2015 and was the Clinical Director of the Division of Endocrinology from 2016 to 2021. Currently, he co-directs the Baltimore Metropolitan Diabetes Regional Partnership, focusing on improving access to diabetes prevention and management programs. As a physician-scientist, Dr. Mathioudakis leads multiple research studies funded by the NIH, private philanthropic organizations (Helmsley Charitable Trust), non-profit organizations (Breakthrough T1D), and industry. His research focuses on the effectiveness of automated diabetes prevention programs and strategies to reduce racial disparities in diabetes technology access. He also collaborates nationally to enhance care for people with type 1 diabetes. Holding a joint appointment in the Division of Biomedical Informatics and Data Science, Dr. Mathioudakis integrates machine learning and AI in diabetes research. He has served on the national Epic Endocrinology Specialty Steering Board and chaired the Type 2 Diabetes Prognostics Working Group for the Precision Medicine Diabetes Initiative. Committed to education, he frequently lectures on endocrinology, epidemiology, and health informatics. Dr. Mathioudakis is rated as a Distinguished provider by MediFind in the treatment of Type 2 Diabetes (T2D). His top areas of expertise are Type 2 Diabetes (T2D), Type 1 Diabetes (T1D), Low Blood Sugar, Maturity Onset Diabetes of the Young, and Pancreaticoduodenectomy.

Justin Tcheugui is an Endocrinologist in Baltimore, Maryland. Dr. Tcheugui is rated as a Distinguished provider by MediFind in the treatment of Type 2 Diabetes (T2D). His top areas of expertise are Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Type 1 Diabetes (T1D), and Gestational Diabetes.

Dr. Sudipa Sarkar is an assistant professor of medicine at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include endocrinology. She received her M.D. from Yale School of Medicine. She completed her residency in internal medicine at Yale-New Haven Hospital and performed a fellowship in endocrinology, diabetes and metabolism at Vanderbilt University Medical Center. Dr. Sarkar joined the Johns Hopkins faculty in 2017. Dr. Sarkar is rated as a Distinguished provider by MediFind in the treatment of Type 2 Diabetes (T2D). Her top areas of expertise are Type 2 Diabetes (T2D), Diabetic Retinopathy, Maturity Onset Diabetes of the Young, Diabetic Neuropathy, and Sleeve Gastrectomy.

Sherita Golden is an Endocrinologist in Baltimore, Maryland. Dr. Golden is rated as a Distinguished provider by MediFind in the treatment of Type 2 Diabetes (T2D). Her top areas of expertise are Type 1 Diabetes (T1D), Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Obesity, and Hormone Replacement Therapy (HRT).

Christopher Ish, M.D., practices internal medicine and pediatrics at Johns Hopkins Community Physicians Glen Burnie. He also serves as office medical director at the practice. Dr. Ish received his medical degree from the University of Medicine and Dentistry of New Jersey and completed his residency training in internal medicine and pediatrics at University of Maryland Medical Center in Baltimore. He is an instructor of medicine at The Johns Hopkins University School of Medicine in Baltimore. Dr. Ish is rated as an Experienced provider by MediFind in the treatment of Type 2 Diabetes (T2D). His top areas of expertise are Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Sitosterolemia, and Scleroderma.

Ritha Chea, M.D., practices internal medicine and pediatrics at Johns Hopkins Community Physicians Glen Burnie. She received her medical degree from Wayne State University School of Medicine in Detroit. She completed her residency in internal medicine and pediatrics at University of Maryland Medical Center in Baltimore. Dr. Chea is rated as an Experienced provider by MediFind in the treatment of Type 2 Diabetes (T2D). Her top areas of expertise are Type 2 Diabetes (T2D), Sitosterolemia, Osteomyelitis in Children, and High Cholesterol.

Patrick Dantzer, M.D., practices pediatrics at Johns Hopkins Community Physicians Glen Burnie. He received his medical degree from Wayne State University School of Medicine, and also completed his residency in internal medicine & pediatrics at Children's Hospital of Pittsburgh. Dr. Dantzer is rated as an Experienced provider by MediFind in the treatment of Type 2 Diabetes (T2D). His top areas of expertise are Premenstrual Dysphoric Disorder, Acute Cerebellar Ataxia, Maturity Onset Diabetes of the Young, and Type 2 Diabetes (T2D).

Kristen Peichert, M.D., practices internal medicine at JHCP Glen Burnie. She received her medical degree from George Washington University School of Medicine and completed her residency in internal medicine at University of Virginia School of Medicine. She attended Wake Forest University for her undergraduate degree. She is originally from White Plains, NY and has traveled up and down the east coast of her various training and schooling. Dr. Peichert has now happily settled in Baltimore, making it her permanent home in 2011, where she lives with her husband and two children. Dr. Peichert is rated as an Experienced provider by MediFind in the treatment of Type 2 Diabetes (T2D). Her top areas of expertise are Type 2 Diabetes (T2D), Doxorubicin-Induced Cardiomyopathy, Cardiomyopathy Due to Anthracyclines, and Maturity Onset Diabetes of the Young.

Kathleen Prendergast is an Endocrinologist in Glen Burnie, Maryland. Dr. Prendergast is rated as a Distinguished provider by MediFind in the treatment of Type 2 Diabetes (T2D). Her top areas of expertise are Type 2 Diabetes (T2D), Diabetic Neuropathy, Maturity Onset Diabetes of the Young, and Hypothyroidism.

Marie-alberte Boursiquot is a primary care provider, practicing in Internal Medicine in Glen Burnie, Maryland. Dr. Boursiquot is rated as an Experienced provider by MediFind in the treatment of Type 2 Diabetes (T2D). Her top areas of expertise are Cerebellar Degeneration, Glucocorticoid-Remediable Aldosteronism, Hypertension, and Familial Hypertension.

Anisha Bassi is a primary care provider, practicing in Family Medicine in Glen Burnie,, Maryland. Dr. Bassi is rated as an Experienced provider by MediFind in the treatment of Type 2 Diabetes (T2D). Her top areas of expertise are Glucocorticoid-Remediable Aldosteronism, Hypertension, Familial Hypertension, Hernia Surgery, and Gastrostomy.

Daljit Sawhney is a primary care provider, practicing in Internal Medicine in Glen Burnie, Maryland. Dr. Sawhney is rated as an Experienced provider by MediFind in the treatment of Type 2 Diabetes (T2D). His top areas of expertise are Diabetic Nephropathy, Generalized Anxiety Disorder (GAD), Type 2 Diabetes (T2D), and High Cholesterol.

Kalpana Atluri is a primary care provider, practicing in Internal Medicine in Baltimore, Maryland. Dr. Atluri is rated as an Experienced provider by MediFind in the treatment of Type 2 Diabetes (T2D). Her top areas of expertise are Nephrosclerosis, Renovascular Hypertension, Maturity Onset Diabetes of the Young, and Glucocorticoid-Remediable Aldosteronism.

Jonathan Rich is a primary care provider, practicing in Internal Medicine in Baltimore, Maryland. Dr. Rich is rated as a Distinguished provider by MediFind in the treatment of Type 2 Diabetes (T2D). His top areas of expertise are Heart Failure, Hypertension, Type 2 Diabetes (T2D), Heart Transplant, and Lung Transplant.

Kashif Munir is an Endocrinologist in Baltimore, Maryland. Dr. Munir is rated as a Distinguished provider by MediFind in the treatment of Type 2 Diabetes (T2D). His top areas of expertise are Type 2 Diabetes (T2D), Thyroid Cancer, Thyroid Storm, Pituitary Tumor, and Thyroidectomy.

Anthony J. Harrell, M.D., practices internal medicine at Johns Hopkins Community Physicians Greater Dundalk. He received his medical degree from Meharry Medical College in Nashville, and completed his residency at Baptist Hospital in Tennessee. Dr. Harrell is rated as an Advanced provider by MediFind in the treatment of Type 2 Diabetes (T2D). His top areas of expertise are Familial Combined Hyperlipidemia, Xanthoma, Cirrhosis, and High Cholesterol.

Dr. Rita Kalyani is a Professor of Medicine at Johns Hopkins School of Medicine. She graduated with an undergraduate degree from Harvard College and completed her medical degree, residency, and fellowship at Johns Hopkins. She also obtained a Masters in Health Science degree in Clinical Investigation from the Johns Hopkins Bloomberg School of Public Health. As a NIH-funded clinician scientist, Dr. Kalyani has authored over 175 peer-reviewed publications and built a research program focused on understanding the factors leading to development of diabetes complications, particularly in high-risk populations. She has conducted epidemiological and patient-oriented research that has led to fundamental discoveries regarding the development of skeletal muscle loss, physical disability, and frailty in diabetes. She has also spearheaded studies investigating sex differences in cardiovascular disease and diabetes which have influenced primary prevention guidelines. Dr. Kalyani launched the Diabetes Management Service for Johns Hopkins’ Total Pancreatectomy Islet Auto Transplant Program in 2011. She is the co-founder of the Johns Hopkins Diabetes POC-IT Guide for healthcare professionals. She is also the founder and past Editor-in-Chief of the Johns Hopkins Patient Website to Diabetes. Dr. Kalyani has been the Chief Scientific and Medical Officer of the American Diabetes Association since 2025. She previously served as President of Medicine & Science on the ADA's National Board of Directors. She continues to have a clinical practice as an adult endocrinologist. Dr. Kalyani is rated as an Advanced provider by MediFind in the treatment of Type 2 Diabetes (T2D). Her top areas of expertise are Seasonal Affective Disorder (SAD), Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Pancreatectomy, and Islet Cell Transplantation.

Dr. Donner's clinical and research interests have focused on the prevention of complications in patients with type 1 and 2 diabetes. For 6 years, he was the Associate Medical Director of the Joslin Diabetes Center affiliate at the University of Maryland, and then Medical Director from 2004 - 2010. After joining the faculty at Johns Hopkins University in 2010, his clinical and research interests became fully dedicated to diabetes. He became the Director of The Johns Hopkins Diabetes Center in 2011. He has been a clinical investigator in a number of NIH- and industry-funded diabetes research trials. Dr. Donner was a co-PI in the NIH-funded Veterans Affairs Implantable Insulin Pump Study, a Co-PI on the NIDDK-funded Diabetes Control and Complications Trial / Epidemiology of Diabetes Intervention and Complications (DCCT / EDIC) Study for 16 years, and Co-PI for the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) for 7 years. Recently, he has served as PI for the Durable-response therapy Evaluation For Early or New-onset type 1 Diabetes (DEFEND-1). Dr. Donner is currently collaborating with Dr. Abdel Hamad in Immunology on preventing B-regulatory cell apoptosis using a novel monoclonal antibody targeting the presumptive apoptotic factor. This antibody prevents the development of type 1 diabetes in non obese diabetic mice. Dr. Donner is the PI for Johns Hopkins for TrialNet, a multicenter, international consortium of investigators studying ways to prevent Type 1 diabetes and preserve insulin secretion in individuals with newly diagnosed Type 1 diabetes. He is also a PI for a study investigating FIAsp, a faster-acting insulin aspart in subjects with type 1 diabetes, and is working with investigators at the Johns Hopkins School of Engineering on an implantable insulin pump which delivers insulin intravenously. Dr. Donner is rated as an Advanced provider by MediFind in the treatment of Type 2 Diabetes (T2D). His top areas of expertise are Type 1 Diabetes (T1D), Diabetic Nephropathy, Type 2 Diabetes (T2D), and Maturity Onset Diabetes of the Young.